Drug manufacturers who are in partnership with the U.S. government, plans to start active production of a vaccine against COVID-19 by the end of summer. On 14 July, reports Reuters, citing an unnamed official of the White house.
The official added that the administration is already working with companies to improve their capacities and the acquisition of materials.
According to the Agency, the administration of the President of the United States Donald trump is still financed the development of four vaccines COVID-19 with his Warp Speed program Operation, the purpose of which is to produce 300 million doses of vaccine by the end of 2021.
In particular, the US government has allocated grants worth several hundred million dollars to more than $1 billion to Johnson & Johnson, Moderna Inc, AstraZeneca Plc and Novovax Inc.
The world health organization believes that the coronavirus would pose a serious threat, until they invent a vaccine. According to the head of the European Agency of medicines Marco Kavaleri, in the best case, the vaccine will be ready next year. May 15, U.S. President Donald trump suggested that the coronavirus vaccine can be developed and tested by the end of 2020.
According to who, currently about 120 trials of a vaccine against coronavirus SARS-COV-2 / COVID-19 worldwide. While 17 of the vaccines now have on the people.